To directly attenuate FasL-mediated apoptosis in β cells, we generated a decoy receptor 3 (DcR3) transgenic mouse strain and investigated the therapeutic potential of DcR3 in T1D [20]. Here, TNFRSF6B is linked to type 1 diabetes mellitus.